Nutrition 21 welcomes patent & IP attorney as general counsel
Nutrition 21, LLC hired Sara O’Brien has joined as General Counsel of JDS Therapeutics, and its wholly owned subsidiary Nutrition 21.
Ms. O’Brien previously worked in the Intellectual Property departments of Willkie Farr & Gallagher and Ropes & Gray, where she most recently specialized in patent litigation. She has experience in intellectual property work in the pharmaceutical and biotechnology sectors as well as intellectual property portfolio management. Her litigation experience encompasses a range of technologies, including biologics, pharmaceuticals, computer software, and other technologies.
“Sara’s intellectual property experience and industry knowledge make her a prime addition to the Nutrition 21 team,” said Michael Satow, CEO and President of Nutrition 21. “We view her role as a sign of our commitment and dedication to supplying our customers with patent protected, clinically substantiated, and innovative ingredients. We are confident that Sara will play a vital role in our business.”
